Literature DB >> 22241377

Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift.

Sanjeev Saksena.   

Abstract

Mesh：

Year:  2012        PMID： 22241377     DOI： 10.1007/s10840-012-9663-8

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  14 in total

1.  Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Authors:  Ilan Goldenberg; Arthur J Moss; Scott McNitt; Wojciech Zareba; W Jackson Hall; Mark L Andrews; David J Wilber; Helmut U Klein
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

2.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Authors:  Ilan Goldenberg; Anant K Vyas; W Jackson Hall; Arthur J Moss; Hongyue Wang; Hua He; Wojciech Zareba; Scott McNitt; Mark L Andrews
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

Review 3.  Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.

Authors:  Simon de Denus; Cynthia A Sanoski; Jörg Carlsson; Grzegorz Opolski; Sarah A Spinler
Journal:  Arch Intern Med       Date:  2005-02-14

4.  Twenty-five years of implantable defibrillator practice in the USA: are we ready for globalization?

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2011-01       Impact factor: 1.900

5.  Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

Authors:  Sanjeev Saksena; April Slee; Albert L Waldo; Nick Freemantle; Mathew Reynolds; Yves Rosenberg; Snehal Rathod; Shannon Grant; Elizabeth Thomas; D George Wyse
Journal:  J Am Coll Cardiol       Date:  2011-11-01       Impact factor: 24.094

6.  Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.

Authors:  Akshay S Desai; Eldrin F Lewis; Rebecca Li; Scott D Solomon; Susan F Assmann; Robin Boineau; Nadine Clausell; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Sonja McKinlay; Eileen O'Meara; Tamaz Shaburishvili; Bertram Pitt; Marc A Pfeffer
Journal:  Am Heart J       Date:  2011-11-08       Impact factor: 4.749

7.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

Authors:  Rukshen Weerasooriya; Paul Khairy; Jean Litalien; Laurent Macle; Meleze Hocini; Frederic Sacher; Nicolas Lellouche; Sebastien Knecht; Matthew Wright; Isabelle Nault; Shinsuke Miyazaki; Christophe Scavee; Jacques Clementy; Michel Haissaguerre; Pierre Jais
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

8.  Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Authors:  Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

9.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

10.  Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators.

Authors:  Iwona Cygankiewicz; John Gillespie; Wojciech Zareba; Mary W Brown; Ilan Goldenberg; Helmut Klein; Scott McNitt; Slava Polonsky; Mark Andrews; Edward M Dwyer; W Jackson Hall; Arthur J Moss
Journal:  Heart Rhythm       Date:  2008-12-24       Impact factor: 6.343
View more
  2 in total

1.  Tailoring interventional arrhythmia therapy to individual patients: seeking the Art and the Science of Cardiac Electrophysiology in 2016.

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2016-01-30       Impact factor: 1.900

2.  Antiarrhythmic therapy--the paradigm shifts in 2012: will it be enough to result in improved health care policies?

Authors:  S Saksena
Journal:  J Interv Card Electrophysiol       Date:  2013-01       Impact factor: 1.900
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.